Viewing data from:

IPRATROPIUM BROMIDE

ANDA

IPRATROPIUM BROMIDE | A075693 | THE RITEDOSE CORP

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 9 NDCs

Highest NADAC/Unit

$0.1139

per ml

Lowest NADAC/Unit

$0.1063

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
76204010001IPRATROPIUM BR 0.02% SOLN	$0.1139	ML	Generic	—	2026-08-19
76204010030IPRATROPIUM BR 0.02% SOLN	$0.1139	ML	Generic	—	2026-08-19
00378797055IPRATROPIUM BR 0.02% SOLN	$0.1139	ML	Generic	—	2026-08-19
00378797093IPRATROPIUM BR 0.02% SOLN	$0.1139	ML	Generic	—	2026-08-19
60687039483IPRATROPIUM BR 0.02% SOLN	$0.1139	ML	Generic	—	2026-08-19
76204010060IPRATROPIUM BR 0.02% SOLN	$0.1089	ML	Generic	—	2026-08-19

Showing 6 of 9 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 7 NDCs (7 FSS)

Lowest Price

$2.81

Highest Price

$12.00

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00378-7970-52IPRATROPIUM BR 0.02% SOLN,INHL,2.5ML	$2.81	FSS	Mylan Pharmaceuticals, Inc.	12/31/2027
00378-7970-55IPRATROPIUM BR 0.02% SOLN,INHL,2.5ML,UD	$3.77	FSS	Mylan Pharmaceuticals, Inc.	12/31/2027
00378-7970-91IPRATROPIUM BR 0.02% SOLN,INHL,2.5ML	$6.78	FSS	Mylan Pharmaceuticals, Inc.	12/31/2027
00378-7970-93IPRATROPIUM BR 0.02% SOLN,INHL,2.5ML,UD	$3.37	FSS	Mylan Pharmaceuticals, Inc.	12/31/2027
76204-0100-25IPRATROPIUM BR 0.02% SOLN,INHL,2.5ML,UD	$5.01	FSS	Golden State Medical Supply, Inc.	06/14/2028
76204-0100-30IPRATROPIUM BR 0.02% SOLN,INHL,2.5ML,UD	$6.00	FSS	Golden State Medical Supply, Inc.	06/14/2028
76204-0100-60IPRATROPIUM BR 0.02% SOLN,INHL,2.5ML,UD	$12.00	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

OLON SPAIPRATROPIUM BROMIDE

DMF 89731991

LUSOCHIMICA SPAIPRATROPIUM BROMIDE

DMF 89791991

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGIPRATROPIUM BROMIDE MONOHYDRATE

DMF 142591999

NEULAND LABORATORIES LTDIPRATROPIUM BROMIDE USP

DMF 151302000

AARTI PHARMALABS LTDIPRATROPIUM BROMIDE

DMF 211792007

AMPHASTAR NANJING PHARMACEUTICALS INCIPRATROPIUM BROMIDE USP

DMF 310362017

SCL LIFESCIENCES LTDIPRATROPIUM BROMIDE USP

DMF 379412025

DERIVADOS QUIMICOS SA FINE CHEMICALSInactiveIPRATROPIUM BROMIDE

DMF 231352009

CIPLA LTDInactiveIPRATROPIUM BROMIDE USP

DMF 298432015

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jan 26, 2001	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.02%

0 patents0 exclusivities▴

SOLUTION;INHALATION | Approved: Jan 26, 2001

No patent or exclusivity listings for this strength.